Tjeerd Barf,Edwin de Zwart,Saskia Verkaik,Niels Hoogenboom,Dennis Demont
申请号：
US15773846
公开号：
US20180318297A1
申请日:
2016.11.04
申请国别(地区):
US
年份:
2018
代理人:
摘要：
In some embodiments, the invention relates to a BTK inhibitor or a pharmaceutically acceptable salt, cocrystal, ester, prodrug, solvate, hydrate or derivative thereof, or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, in some embodiments, the present invention relates to imidazopyrazine compounds, pharmaceutical compositions thereof, and the use of the compounds and pharmaceutical compositions in the treatment of a hyperproliferative disorder, an inflammatory disorder, an immune disorder, or an autoimmune disorder.
